Distinguishing NMS from serotonin syndrome in a patient on multiple psychotropics?

45M on haloperidol 10mg BID and fluoxetine 60mg daily for schizoaffective disorder with comorbid depression. Presented with temperature 40.1°C, severe rigidity, altered mental status (GCS 10), diaphoresis.

Labs: CPK 12,400, WBC 14,200, creatinine 1.9 (baseline 0.9).

The diagnostic challenge: Haloperidol makes NMS a strong possibility. But fluoxetine at 60mg makes serotonin syndrome equally plausible. The clinical overlap is significant.

My questions:

What clinical features help distinguish NMS from SS in an overlap case?
Is dantrolene appropriate if you cannot distinguish the two?
Should both agents be stopped simultaneously?
When do you consider cyproheptadine empirically?

After 72 hours of management, here is our clinical reasoning and outcome:

Distinguishing features that pointed toward NMS:

Lead-pipe rigidity (NMS) vs clonus/hyperreflexia (SS). Our patient had severe generalized rigidity without clonus.
Bradykinetic facies with mask-like expression, typical of NMS.
CPK 12,400 is more consistent with NMS. SS typically causes milder CPK elevation (< 1000) unless severe.
Slow onset over 3 to 5 days (NMS) vs rapid onset within hours of dose change (SS). On history, haloperidol was recently increased from 5mg BID to 10mg BID one week prior.

Management:

Stopped both haloperidol and fluoxetine immediately
Started dantrolene 1 to 2.5 mg/kg IV q6h for the first 48 hours
Aggressive IV hydration targeting urine output > 200 mL/hr to prevent myoglobin-induced AKI
Cooling measures (ice packs, cooled IV fluids)

CPK peaked at 18,000 on day 2, then trended down. Temperature normalized by day 3. Creatinine peaked at 2.4, then recovered. GCS back to 15 by day 4.

For future maintenance after recovery, we will use a second-generation antipsychotic with lower D2 receptor binding affinity (quetiapine or clozapine) instead of haloperidol.

From the ED perspective, the initial management is the same regardless of whether you call it NMS or SS:

Stop all offending agents
Aggressive cooling
IV fluids
Benzodiazepines for agitation (lorazepam 2mg IV, repeat as needed)

The diagnostic distinction matters for two reasons: dantrolene (specific for NMS) and cyproheptadine (specific for SS). In a true overlap case where you genuinely cannot tell, I start both a benzodiazepine drip and dantrolene, and add cyproheptadine if there is any clonus or hyperreflexia.

Regarding cyproheptadine: 12mg initial dose PO/NG, then 4mg q6h. It is a non-selective 5-HT antagonist. Only useful in serotonin syndrome, not harmful in NMS, so it is safe empirically.

2 Answers